Nalaganje...

"Flagellated" cancer cells propel anti-tumor immunity

The use of innate immune receptor agonists in cancer therapies has suffered from many drawbacks. Our recent observations suggest that some of these hurdles can be overcome by introducing flagellin into tumor cells to promote tumor antigen presentation by dendritic cells (DCs) and simultaneously trig...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Garaude, Johan, Blander, J. Magarian
Format: Artigo
Jezik:Inglês
Izdano: Landes Bioscience 2012
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3489752/
https://ncbi.nlm.nih.gov/pubmed/23162764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.20305
Oznake: Označite
Brez oznak, prvi označite!